Denna sida har översatts automatiskt och översättningens korrekthet kan inte garanteras. Vänligen se engelsk version för en källtext.

Let's Get REAL: Family Health Communication Tool in Pediatric Stamcell Transplantation and Cellular Therapy

16 november 2026 uppdaterad av: Washington University School of Medicine

Låt oss bli RIKTIGA: Ett pilotförsök med ett familjehälsokommunikationsverktyg inom pediatrisk stamcellstransplantation och cellterapi

The investigators will conduct a pilot feasibility and efficacy trial of a newly developed family health communication tool (called Let's Get REAL) in increasing youth involvement in real-time stem cell transplant and cellular therapy decisions (SCTCT). The investigators will pilot the intervention among 24 youth and their parents, stratified by youth age (stratum 1, 8-12 years of age and stratum 2, 13-17 years of age).

Studieöversikt

Studietyp

Interventionell

Inskrivning (Beräknad)

60

Fas

  • Inte tillämpbar

Kontakter och platser

Det här avsnittet innehåller kontaktuppgifter för dem som genomför studien och information om var denna studie genomförs.

Studiekontakt

  • Namn: Ginny L Schulz, Ph.D., RN, CPNP-PC
  • Telefonnummer: 314-454-6018
  • E-post: schulz_g@wustl.edu

Studieorter

    • Missouri
      • St Louis, Missouri, Förenta staterna, 63110
        • Rekrytering
        • Washington University School of Medicine
        • Underutredare:
          • Shalini Shenoy, M.D.
        • Kontakt:
          • Ginny L Schulz, Ph.D., RN, CPNP-PC
          • Telefonnummer: 314-454-6018
          • E-post: schulz_g@wustl.edu
        • Huvudutredare:
          • Ginny L Schulz, Ph.D., RN, CPNP-PC
        • Underutredare:
          • Amy McQueen, Ph.D.

Deltagandekriterier

Forskare letar efter personer som passar en viss beskrivning, så kallade behörighetskriterier. Några exempel på dessa kriterier är en persons allmänna hälsotillstånd eller tidigare behandlingar.

Urvalskriterier

Åldrar som är berättigade till studier

8 år och äldre (Barn, Vuxen, Äldre vuxen)

Tar emot friska volontärer

Nej

Kön som är behöriga för studier

Allt

Beskrivning

Inclusion Criteria Youth:

  • Children or adolescents 8-17 years of age referred for SCTCT.
  • Diagnosis of malignant or nonmalignant disorder.
  • Referred for any type of SCTCT. Autologous and allogeneic stem cell and cellular therapies are eligible.
  • Planning to meet with a provider to discuss SCTCT.
  • Must have the ability to understand and willingness to consent to participate after reviewing an IRB approved informed assent document.
  • Must speak English and be cognitively able to participate.

Inclusion Criteria Parents:

  • Parent or guardian of a child 8-17 years of age with any diagnosis referred for any type of SCTCT. Diagnoses may include malignant and nonmalignant disorders. Autologous and allogeneic stem cell and cellular therapies are eligible. Parent or guardian is defined as an adult who usually cares for the youth and has authority to make medical decisions for them.
  • Must have the ability to understand and willingness to consent to participate after reviewing an IRB approved informed consent document.
  • Must speak English and be cognitively able to participate.

Exclusion Criteria Youth:

  • Active medical problems severe enough to preclude study participation at the time of recruitment.

    • Patients who are otherwise eligible, but whose primary transplant physician does not want them to participate in the study.
  • Lacks cognitive capacity to complete study activities, as determined by consenting professional.

Exclusion Criteria Parents:

  • Their youth referred for SCTCT does not assent to participate.

Studieplan

Det här avsnittet ger detaljer om studieplanen, inklusive hur studien är utformad och vad studien mäter.

Hur är studien utformad?

Designdetaljer

  • Primärt syfte: Hälsovårdsforskning
  • Tilldelning: Icke-randomiserad
  • Interventionsmodell: Parallellt uppdrag
  • Maskning: Ingen (Open Label)

Vapen och interventioner

Deltagargrupp / Arm
Intervention / Behandling
Experimentell: Let's Get REAL family health communication tool: Patients (8-12 years of age)

Patients and parent(s) will be given the Let's Get REAL family health communication tool to use up to one month prior to their SCTCT consultation visit. It is a guide for pediatric patients and their families to learn about and discuss SCTCT. Participants will complete demographic and baseline surveys prior to using the tool, and then additional surveys up to one month after SCTCT consultation visit and up to one month post-discharge from SCTCT. SCTCT consultation visits will be audio-recorded. Participants may also participate in an optional semi-structured interview up to 8 weeks after SCTCT consultation.

Family health communication tool

Experimentell: Let's Get REAL family health communication tool: Patients (13-17 years of age)

Patients and parent(s) will be given the Let's Get REAL family health communication tool to use up to one month prior to their SCTCT consultation visit. It is a guide for pediatric patients and their families to learn about and discuss SCTCT. Participants will complete demographic and baseline surveys prior to using the tool, and then additional surveys up to one month after SCTCT consultation visit and up to one month post-discharge from SCTCT. SCTCT consultation visits will be audio-recorded. Participants may also participate in an optional semi-structured interview up to 8 weeks after SCTCT consultation.

Family health communication tool

Experimentell: Let's Get REAL family health communication tool: Parents

Patients and parent(s) will be given the Let's Get REAL family health communication tool to use up to one month prior to their SCTCT consultation visit. It is a guide for pediatric patients and their families to learn about and discuss SCTCT. Participants will complete demographic and baseline surveys prior to using the tool, and then additional surveys up to one month after SCTCT consultation visit and up to one month post-discharge from SCTCT. SCTCT consultation visits will be audio-recorded. Participants may also participate in an optional semi-structured interview up to 8 weeks after SCTCT consultation.

Family health communication tool

Vad mäter studien?

Primära resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
Feasibility of intervention as measured by the Feasibility of Intervention questionnaire
Tidsram: Up to 4 weeks after SCTCT consultation (estimated to be week 8)

This is a 4-item scale that youth and their parents report feasibility of the intervention on a 5-point Likert scale ranging from 'Completely disagree' to Completely agree'. A higher score indicates greater feasibility.

Up to 4 weeks after SCTCT consultation (estimated to be week 8)
Acceptability of intervention as measured by the Acceptability of Intervention questionnaire
Tidsram: Up to 4 weeks after SCTCT consultation (estimated to be week 8)

This is a 4-item scale that youth and their parents report acceptability of the intervention on a 5-point Likert scale ranging from 'Completely disagree' to Completely agree'. A higher score indicates greater acceptability.

Up to 4 weeks after SCTCT consultation (estimated to be week 8)
Appropriateness of intervention as measured by the Intervention of Appropriateness questionnaire
Tidsram: Up to 4 weeks after SCTCT consultation (estimated to be week 8)

This is a 4-item scale that youth and their parents report appropriateness of the intervention on a 5-point Likert scale ranging from 'Completely disagree' to Completely agree'. A higher score indicates greater appropriateness.

Up to 4 weeks after SCTCT consultation (estimated to be week 8)
Feasibility of intervention as measured qualitatively
Tidsram: Up to 8 weeks after SCTCT consultation (estimated to be week 16)

Content analysis of open-ended survey responses and quotations from individual interviews. Will be collecting number of feasibility content codes.

Up to 8 weeks after SCTCT consultation (estimated to be week 16)
Acceptability of intervention as measured qualitatively
Tidsram: Up to 8 weeks after SCTCT consultation (estimated to be week 16)

Content analysis of open-ended survey responses and quotations from individual interviews. Will be collecting number of acceptability content codes.

Up to 8 weeks after SCTCT consultation (estimated to be week 16)
Appropriateness of intervention as measured qualitatively
Tidsram: Up to 8 weeks after SCTCT consultation (estimated to be week 16)

Content analysis of open-ended survey responses and quotations from individual interviews. Will be collecting number of appropriateness content codes.

Up to 8 weeks after SCTCT consultation (estimated to be week 16)

Sekundära resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
Antal patienter som valde SCTCT
Tidsram: Upp till 4 veckor efter SCTCT-konsultation (beräknas vecka 8)
Upp till 4 veckor efter SCTCT-konsultation (beräknas vecka 8)
Difference in feasibility scores in those 8-12 years of age and those 13-17 years of age as measured by the Feasibility of Intervention questionnaire
Tidsram: Up to 4 weeks after SCTCT consultation (estimated to be week 8)

This is a 4-item scale that youth and their parents report feasibility of the intervention on a 5-point Likert scale ranging from 'Completely disagree' to Completely agree'. A higher score indicates greater feasibility.

Up to 4 weeks after SCTCT consultation (estimated to be week 8)
Difference in acceptability scores in those 8-12 years of age and those 13-17 years of age as measured by the Acceptability of Intervention questionnaire
Tidsram: Up to 4 weeks after SCTCT consultation (estimated to be week 8)

This is a 4-item scale that youth and their parents report acceptability of the intervention on a 5-point Likert scale ranging from 'Completely disagree' to Completely agree'. A higher score indicates greater acceptability.

Up to 4 weeks after SCTCT consultation (estimated to be week 8)
Difference in appropriateness scores in those 8-12 years of age and those 13-17 years of age as measured by the Intervention of Appropriateness questionnaire
Tidsram: Up to 4 weeks after SCTCT consultation (estimated to be week 8)

This is a 4-item scale that youth and their parents report appropriateness of the intervention on a 5-point Likert scale ranging from 'Completely disagree' to Completely agree'. A higher score indicates greater appropriateness.

Up to 4 weeks after SCTCT consultation (estimated to be week 8)
Perceived levels of decision-making involvement in youth 8-17 years of age and their parents as measured by the Decision Making Involvement Scale
Tidsram: Up to 4 weeks after SCTCT consultation (estimated to be week 8)

This is a 30-item scale that youth and their parents report youth involvement behaviors in a decision related to their illness on a 4-point Likert scale ranging from 'A Little Bit' to 'A Lot'. The higher the subscale score (child seek, child express, parent seek, parent express, and joint/options), the more that behavior or type of involvement occurred in the decision making process.

Up to 4 weeks after SCTCT consultation (estimated to be week 8)
Observed levels of decision-making involvement in youth 8-17 years of age and their parents
Tidsram: Up to 4 weeks after SCTCT consultation (estimated to be week 8)

Number of utterance occurrences for the following: 1) who uttered (youth, parent), 2) was utterance prompted (yes/no), if so, by who, 3) type of utterance (questions, opinion, concern, other), and 4) content of utterance (prognosis, side effect, expectation).

Up to 4 weeks after SCTCT consultation (estimated to be week 8)
Change in youth-parent communication as measured by the Likert-type Parent-Adolescent Communication Scale
Tidsram: Up to 4 weeks prior to SCTCT consultation and up to 4 weeks after SCTCT consultation (estimated to be 8 weeks)

This is a 20-item scale that youth and parents report the degree of openness in family communication and the extent of problems with family communications on a 5-point Likert ranging from 'strongly disagree' to 'strongly agree'. A higher score on the degree of openness subscale indicates better communication between parent and adolescent. For extent of problems subscale, a higher score indicates more problems in the parent-child communication.

Up to 4 weeks prior to SCTCT consultation and up to 4 weeks after SCTCT consultation (estimated to be 8 weeks)
Change in the level of youth's general anxiety as measured by the Likert-type PROMIS Anxiety 8a Short Form or parent proxy
Tidsram: Up to 4 weeks prior to SCTCT consultation and up to 4 weeks after SCTCT consultation (estimated to be 8 weeks)

This is an 8-item scale that measures youth's general anxiety in those 8-17 years of age on a 5-point Likert scale ranging from 'never' to 'almost always'.

Up to 4 weeks prior to SCTCT consultation and up to 4 weeks after SCTCT consultation (estimated to be 8 weeks)
Level of decisional conflict as measured by the Likert-type Decisional Conflict Scale
Tidsram: Up to 4 weeks after SCTCT consultation (estimated to be week 8)

This is a 10-item scale that youth and parents report their personal uncertainty and decisional conflict related to a specific decision. We are using the question format as it is recommended for those with limited reading or response skills. They respond 'Yes', 'No, or 'Unsure'. A total decision conflict score ranges from 0 (no decisional conflict) to 100 (extremely high decision conflict). Higher scores on subscales uncertainty, informed, values clarity, and support reflect feeling extremely uncertain about the best choice, feeling extremely uninformed, feeling extremely unclear about personal values, and feeling extremely unsupported in decision making respectively.

Up to 4 weeks after SCTCT consultation (estimated to be week 8)
Youth-parent congruence of youth decision making involvement as measured by two Likert type statements
Tidsram: Up to 4 weeks after SCTCT consultation (estimated to be week 8)

Number of dyads that agree on these two statements measured on a 4-point Likert scale ranging from 'Not at all' to 'A lot': 1)"I/my child should be involved in future talks about transplant" and 2) "I/my child wants to be involved in future talks about transplant".

Up to 4 weeks after SCTCT consultation (estimated to be week 8)
Satisfaction with the decision making involvement as measured by one Likert type statement
Tidsram: Up to 4 weeks after SCTCT consultation (estimated to be week 8)

This is a one item statement, "I am satisfied with my/my child's involvement in the transplant decision making process", measured on a 4-point Likert scale ranging from 'Not at all' to 'A lot'. A higher score indicates more satisfaction.

Up to 4 weeks after SCTCT consultation (estimated to be week 8)

Samarbetspartners och utredare

Det är här du hittar personer och organisationer som är involverade i denna studie.

Utredare

  • Huvudutredare: Ginny Schulz, Ph.D., RN, CPNP-PC, Washington University School of Medicine

Publikationer och användbara länkar

Den som ansvarar för att lägga in information om studien tillhandahåller frivilligt dessa publikationer. Dessa kan handla om allt som har med studien att göra.

Studieavstämningsdatum

Dessa datum spårar framstegen för inlämningar av studieposter och sammanfattande resultat till ClinicalTrials.gov. Studieposter och rapporterade resultat granskas av National Library of Medicine (NLM) för att säkerställa att de uppfyller specifika kvalitetskontrollstandarder innan de publiceras på den offentliga webbplatsen.

Studera stora datum

Studiestart (Faktisk)

26 november 2024

Primärt slutförande (Beräknad)

31 augusti 2027

Avslutad studie (Beräknad)

31 augusti 2027

Studieregistreringsdatum

Först inskickad

12 november 2024

Först inskickad som uppfyllde QC-kriterierna

12 november 2024

Första postat (Faktisk)

14 november 2024

Uppdateringar av studier

Senaste uppdatering publicerad (Faktisk)

17 november 2026

Senaste inskickade uppdateringen som uppfyllde QC-kriterierna

16 november 2026

Senast verifierad

1 november 2026

Mer information

Termer relaterade till denna studie

Plan för individuella deltagardata (IPD)

Planerar du att dela individuella deltagardata (IPD)?

NEJ

Läkemedels- och apparatinformation, studiedokument

Studerar en amerikansk FDA-reglerad läkemedelsprodukt

Nej

Studerar en amerikansk FDA-reglerad produktprodukt

Nej

Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .

Prenumerera